A cross-sectional study of docosahexaenoic acid status and cognitive outcomes in females of reproductive age with phenylketonuria

Journal of Inherited Metabolic Disease

Volumn 34, Issue 2, 2011, Pages 455-463

  Yi, Sarah H L ^a   Kable, Julie A ^b   Evatt, Marian L ^b,c   Singh, Rani H ^a,b,d  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ERYTHROCYTE LEVEL; EXECUTIVE FUNCTION; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; LEARNING; MEMORY; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PHENYLKETONURIA; SCHOOL CHILD; TASK PERFORMANCE; VERBAL COMMUNICATION;

ADOLESCENT; ADULT; BRAIN; CHILD; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DOCOSAHEXAENOIC ACIDS; ERYTHROCYTES; FATTY ACIDS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; PHENYLKETONURIAS; TREATMENT OUTCOME;

EID: 79955682779     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-011-9277-9     Document Type: Article

References (58)

1. Acosta PB, Yannicelli S, Singh R et al (2001) Intake and blood levels of fatty acids in treated patients with phenylketonuria. J Pediatr Gastroenterol Nutr 33:253-259 (Pubitemid 32947325)
2. Agostoni C, Massetto N, Biasucci G et al (2000) Effects of long-chain polyunsaturated fatty acid supplementation on fatty acid status and visual function in treated children with hyperphenylalaninemia. J Pediatr 137:504-509
3. Agostoni C, Harvie A, McCulloch DL et al (2006) A randomized trial of long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria. Dev Med Child Neurol 48:207-212 (Pubitemid 44404267)
4. Arbuckle LD, MacKinnon MJ, Innis SM (1994) Formula 18:2(n-6) and 18:3(n-3) content and ratio influence long-chain polyunsaturated fatty acids in the developing piglet liver and central nervous system. J Nutr 124:289-298 (Pubitemid 24093969)
5. Bazan NG (2009) Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. Prostaglandins Leukot Essent Fatty Acids 81:205-211
6. Beblo S, Reinhardt H, Muntau AC, Mueller-Felber W, Roscher AA, Koletzko B (2001) Fish oil supplementation improves visual evoked potentials in children with phenylketonuria. Neurology 57:1488-1491 (Pubitemid 32995735)
7. Beblo S, Reinhardt H, Demmelmair H, Muntau AC, Koletzko B (2007) Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria. J Pediatr 150:479-484 (Pubitemid 46602320)
8. Bickel H, Gerrard J, Hickmans EM (1953) Influence of phenylalanine intake on phenylketonuria. Lancet 265:812-813
9. Birch EE, Garfield S, Castaneda Y, Hughbanks-Wheaton D, Uauy R, Hoffman D (2007) Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula. Early Hum Dev 83:279-284 (Pubitemid 46561172)
10. Blank C, Neumann MA, Makrides M, Gibson RA (2002) Optimizing DHA levels in piglets by lowering the linoleic acid to alpha-linolenic acid ratio. J Lipid Res 43:1537-1543
11. Brumm VL, Azen C, Moats RA et al (2004) Neuropsychological outcome of subjects participating in the PKU adult collaborative study: a preliminary review. J Inherit Metab Dis 27:549-566 (Pubitemid 39295097)
12. Carver JD, Benford VJ, Han B, Cantor AB (2001) The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects. Brain Res Bull 56:79-85 (Pubitemid 33028885)
13. Cerone R, Schiaffino MC, Di Stefano S, Veneselli E (1999) Phenylketonuria: diet for life or not? Acta Paediatr 88:664-666
14. Channon S, Mockler C, Lee P (2005) Executive functioning and speed of processing in phenylketonuria. Neuropsychology 19:679-686 (Pubitemid 41429115)
15. Channon S, Goodman G, Zlotowitz S, Mockler C, Lee PJ (2007) Effects of dietary management of phenylketonuria on long-term cognitive outcome. Arch Dis Child 92:213-218 (Pubitemid 46423789)
16. Cockburn F, Clark BJ, Caine EA et al (1996) Fatty acids in the stability of neuronal membrane: relevance to PKU. Int Pediatr 11:56-60 (Pubitemid 26319425)
17. de Groot RH, Adam J, Jolles J, Hornstra (2004) Alpha-linolenic acid supplementation during human pregnancy does not effect cognitive functioning. Prostaglandins Leukot Essent Fatty Acids 70:41-47 (Pubitemid 38021640)
18. de Groot RH, Hornstra G, Jolles J (2007) Exploratory study into the relation between plasma phospholipid fatty acid status and cognitive performance. Prostaglandins Leukot Essent Fatty Acids 76:165-172 (Pubitemid 46366657)
19. Delis DC, Kaplan E, Kramer JH (2001) Delis-Kaplan Executive Function System: Technical Manual. The Psychological Corporation, San Antonio, TX
20. DeRoche K, Welsh M (2008) Twenty-five years of research on neurocognitive outcomes in early-treated phenylketonuria: intelligence and executive function. Dev Neuropsychol 33:474-504 (Pubitemid 351883465)
21. Dunn LM, Dunn LM (1997) Examiner's Manual for the Peabody Picture Vocabulary Test-Third Edition (PPVT-III). American Guidance Service, Circle Pines, MN
22. Engstrom K, Saldeen AS, Yang B, Mehta JL, Saldeen T (2009) Effect of fish oils containing different amounts of EPA, DHA, and antioxidants on plasma and brain fatty acids and brain nitric oxide synthase activity in rats. Ups J Med Sci 114:206-213
23. Feldmann R, Denecke J, Grenzebach M, Weglage J (2005) Frontal lobe-dependent functions in treated phenylketonuria: blood phenylalanine concentrations and long-term deficits in adolescents and young adults. J Inherit Metab Dis 28:445-455 (Pubitemid 40753672)
24. Fisch RO, Chang PN, Weisberg S, Guldberg P, Guttler F, Tsai MY (1995) Phenylketonuric patients decades after diet. J Inherit Metab Dis 18:347-353
25. Galli C, Agostoni C, Mosconi C, Riva E, Salari PC, Giovannini M (1991) Reduced plasma C-20 and C-22 polyunsaturated fatty acids in children with phenylketonuria during dietary intervention. J Pediatr 119:562-567
26. Holte LL, Peter SA, Sinnwell TM, Gawrisch K (1995) 2 H nuclear magnetic resonance order parameter profiles suggest a change of molecular shape for phosphatidylcholines containing a polyunsaturated acyl chain. Biophys J 68:2396-2403
27. Infante JP, Huszagh VA (2001) Impaired arachidonic (20:4n-6) and docosahexaenoic (22:6n-3) acid synthesis by phenylalanine metabolites as etiological factors in the neuropathology of phenylketonuria. Mol Genet Metab 72:185-198 (Pubitemid 34171435)
28. Jenski LJ, Stillwell W (1999) Role of docosahexaenoic acid in determining membrane structure and function. In: Mostofsky D, Yehuda S, Salem N Jr (eds) Fatty acids: physiological and behavioral functions. Human Press, Totowa, pp 41-62
29. Jiang L, Shi Y, Long Y, Yang Z (2009) The influence of orally administered docosahexaenoic acid on monoamine neurotransmitter, nerve growth factor, and brain-derived neurotrophic factor in aged mice. Pharm Biotechnol (Formerly Int J Pharmacogn) 47:584-591
30. Koletzko B, Beblo S, Demmelmair H, Muller-Felber W, Hanebutt FL (2009) Does dietary DHA improve neural function in children? Observations in phenylketonuria. Prostaglandins Leukot Essent Fatty Acids 81:159-164
31. Kris-Etherton PM, Taylor DS, Yu-Poth S et al (2000) Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 71:179S-188S
32. Lagerstedt SA, Hinrichs DR, Batt SM, Magera MJ, Rinaldo P, McConnell JP (2001) Quantitative determination of plasma c8- c26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders. Mol Genet Metab 73:38-45 (Pubitemid 34177622)
33. LaVoie SM, Harding CO, Gillingham MB (2009) Normal Fatty Acid Concentrations in Young Children With Phenylketonuria. Top Clin Nutr 24:333-340
34. Liou YA, King DJ, Zibrik D, Innis SM (2007) Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr 137:945-952 (Pubitemid 46596892)
35. Llorente AM, Jensen CL, Voigt RG, Fraley JK, Berretta MC, Heird WC (2003) Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am J Obstet Gynecol 188:1348-1353 (Pubitemid 36589134)
36. Mazer LM, Yi SH, Singh RH (2010) Docosahexaenoic acid status in females of reproductive age with maple syrup urine disease. J Inherit Metab Dis 33(2):121-7
37. McGrew KS, Woodcock RW (2001) Woodcock-Johnson III Technical Manual. Riverside, Itasca, IL
38. Moseley K, Koch R, Moser AB (2002) Lipid status and long-chain polyunsaturated fatty acid concentrations in adults and adolescents with phenylketonuria on phenylalanine-restricted diet. J Inherit Metab Dis 25:56-64 (Pubitemid 34303227)
39. Moyle JJ, Fox AM, Arthur M, Bynevelt M, Burnett JR (2007a) Meta- analysis of Neuropsychological Symptoms of Adolescents and Adults with PKU. Neuropsychol Rev 17:91-101 (Pubitemid 46889563)
40. Moyle JJ, Fox AM, Bynevelt M, Arthur M, Burnett JR (2007b) A neuropsychological profile of off-diet adults with phenylketonuria. J Clin Exp Neuropsychol 29:436-441 (Pubitemid 46763624)
41. National Institutes of Health Consensus Development Panel (2001) National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16-18, 2000. Pediatrics 108:972-982
42. NIST Chemistry WebBook. 2008. http://webbook.nist.gov. Accessed January 16, 2010.
43. Paine RS (1957) The variability in manifestations of untreated patients with phenylketonuria (phenylpyruvic aciduria). Pediatrics 20:290-302
44. Pawlosky RJ, Hibbeln JR, Novotny JA, Salem N Jr (2001) Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J Lipid Res 42:1257-1265 (Pubitemid 32744249)
45. Poge AP, Baumann K, Muller E, Leichsenring M, Schmidt H, Bremer HJ (1998) Long-chain polyunsaturated fatty acids in plasma and erythrocyte membrane lipids of children with phenylketonuria after controlled linoleic acid intake. J Inherit Metab Dis 21:373-381 (Pubitemid 28356419)
46. Rosell MS, Lloyd-Wright Z, Appleby PN, Sanders TA, Allen NE, Key TJ (2005) Long-chain n-3 polyunsaturated fatty acids in plasma in British meat-eating, vegetarian, and vegan men. Am J Clin Nutr 82:327-334
47. Ryan AS, Nelson EB (2008) Assessing the effect of docosahexaenoic acid on cognitive functions in healthy, preschool children: a randomized, placebo-controlled, double-blind study. Clin Pediatr (Phila) 47:355-362 (Pubitemid 351519654)
48. Salem N Jr, Litman B, Kim HY, Gawrisch K (2001) Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36:945-959 (Pubitemid 33065196)
49. Schrank FA, McGrew KS, Woodcock RW (2001) Technical Abstract (Assessment Service Bulletin No. 2). Riverside, Itasca, IL
50. Slocum RH, Cummings A (1991) Amino acid analysis of physiological samples. In: Hommos F (ed) Techniques in diagnostic human biochemical genetics. Wiley Liss, New York
51. Spector AA (2001) Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty acid for the brain. J Mol Neurosci 16:159-165, discussion 215-121
52. Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643-662
53. van Gool CJ, van Houwelingen AC, Hornstra G (2000) The essential fatty acid status in phenylketonuria patients under treatment. J Nutr Biochem 11:543-547
54. VanZutphen KH, Packman W, Sporri L et al (2007) Executive functioning in children and adolescents with phenylketonuria. Clin Genet 72:13-18 (Pubitemid 47010142)
55. Waisbren SE, Levy HL (1991) Agoraphobia in phenylketonuria. J Inherit Metab Dis 14:755-764
56. Waisbren SE, Zaff J (1994) Personality disorder in young women with treated phenylketonuria. J Inherit Metab Dis 17:584-592 (Pubitemid 24287803)
57. Waisbren SE, Brown MJ, de Sonneville LM, Levy HL (1994) Review of neuropsychological functioning in treated phenylketonuria: an information processing approach. Acta Paediatr Suppl 407:98-103
58. Wassall SR, Stillwell W (2008) Docosahexaenoic acid domains: the ultimate non-raft membrane domain. Chem Phys Lipids 153:57-63